This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Au H-J, Karapetis CS, O'Callaghan CJ, Tu D, Moore MJ, Zalcberg JR, Kennecke H, Shapiro JD, Koski S, Pavlakis N, Charpentier D, Wyld D, Jefford M, Knight GJ, Magoski NM, Brundage MD, Jonker DJ.Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 trial. Journal of Clinical Oncology 27: 1822-1828, No. 11, 10 Apr 2009
Rights and permissions
About this article
Cite this article
Cetuximab improves HRQOL in patients with CRC. Pharmacoecon. Outcomes News 574, 10 (2009). https://doi.org/10.2165/00151234-200905740-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905740-00024